about
Cysteamine: an old drug with new potential.Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro.Carnitine Profile and Effect of Suppletion in Children with Renal Fanconi Syndrome due to Cystinosis.Non-invasive measurements of atherosclerosis in adult cystinosis patients.Improving the prognosis of nephropathic cystinosis.Cystinosis: a new perspective.Clinical and molecular aspects of distal renal tubular acidosis in children.Growth retardation in children with cystinosis.Pediatric lupus nephritis presenting with terminal renal failure.Growth hormone producing prolactinoma in juvenile cystinosis: a simple coincidence?Fertility status in male cystinosis patients treated with cysteamine.Management dilemmas in pediatric nephrology: Cystinosis.First Successful Conception Induced by a Male Cystinosis Patient.Studying nonobstructive azoospermia in cystinosis: histologic examination of testes and epididymis and sperm analysis in a Ctns−/− mouse modelHalitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartratePharmacokinetics of cysteamine in a cystinosis patient treated with hemodialysisDetailed studies of growth hormone secretion in cystinosis patientsCysteamine toxicity in patients with cystinosis[Lipoblastoma and lipoblastomatosis: especially in children]Erratum to: Clinical and molecular aspects of distal renal tubular acidosis in childrenBartter and Gitelman syndromes: Questions of class
P50
Q34328193-C874B2F5-0410-4F33-9EA2-6F0A465317C3Q34388980-1D5DA1D1-C756-4590-8FEE-9F08DFE481CAQ34459489-7D2B4E68-756F-4C28-A19D-C5F83EFF4A89Q35028558-35091F2A-3CBD-4800-B3CA-AAEC3E463E3AQ38239120-DB838DCA-3C6E-4645-8188-A0CEBAC246B1Q38307845-FB03D19B-6D3C-4DC1-B693-2B430D2A0502Q38966493-1AC62E57-D0E4-41FA-ACAB-33628091DB14Q39873364-BDDA57B3-1470-48AB-9F0C-E4EF33F60808Q40678664-716941F7-2818-4CD4-8DAB-C8CFABFE23ECQ41786211-5842A5A9-9936-4710-8361-28AD8A9B7FB0Q44575207-AD07D406-CCD2-44A1-9B6F-8854CADBCD43Q49073643-359F4345-69F9-4C13-B99F-53102E605696Q53359326-18D244A8-A4B3-4833-A50B-D56ADDAB5FA4Q59163960-AF614FF1-1EB8-4CB9-B55B-125DB2705DA3Q59564347-7C1A0846-F753-4947-BFC7-BF45FF42EE08Q82038599-3222C0F4-039F-49B2-8991-8522D4C491C5Q84290178-BE2E23D3-BA34-41CA-8FFF-72600BEFCE93Q84588586-ADAAE2B6-ACE6-4F80-8000-973630856454Q84795557-69ED4B37-59BB-4F18-8946-8FCB83BCC650Q89406558-D370B017-AB5F-4E6B-8097-62A7833B6C49Q91002374-82431DDA-839E-4ABD-A70D-CDCDA03BEB1C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Martine T P Besouw
@en
Martine T P Besouw
@nl
type
label
Martine T P Besouw
@en
Martine T P Besouw
@nl
prefLabel
Martine T P Besouw
@en
Martine T P Besouw
@nl
P31
P496
0000-0002-3452-0683